Today is the last day to visit Xenon Pharmaceuticals Inc. at Booth 1797 in the #AANAM Exhibit Hall before it closes at 4:00 pm! Thank you to everyone who connected with us at the booth, the 5K run, and meeting sessions. @AANmember
Xenon Pharmaceuticals Inc.’s Post
More Relevant Posts
-
Institutional Analyst Inc. I Revelers.IO Media Group | Editor - Beverage, Biotech, Internet, Marijuana and Psychedelic Stock Reviews.
$GOVX Lesson to be learned from Corbus $CRBP $4 to $44, after 1:30 'death knell' reverse split. GeoVax Labs, Inc. Corbus Pharmaceuticals https://lnkd.in/e3aed7mm
To view or add a comment, sign in
-
-
Live webinar about Insife's new PROHALO system!
We are inviting you to our PROHALO webinar on September 7th. The webinar is scheduled to go live at 08:00 AM ET (US), 1:00 PM (UK), and 2:00 PM (Central EU). During the webinar, we will unveil our groundbreaking new solution PROHALO, that has the potential to transform the pharmaceutical landscape for companies of all sizes. Be a part of the change—sign up using the link https://lnkd.in/dXxMVTgK
Be a part of the change—sign up for PROHALO Webinar!
To view or add a comment, sign in
-
There are major changes afoot in drug benefits. Join this webinar to learn about the trends that are shaping how employers are thinking about how medication benefits will be managed in the future.
Webinar last call! Sign up for the Pharmaceutical Strategies Group - PSG Trends in Drug Benefit Design Report webinar tomorrow at 12:30 PM CT. Learn all the highlights from the report, sponsored by Prescryptive. We hope to “see” you there! http://spr.ly/60475SH4H
To view or add a comment, sign in
-
-
At Asembia's AXS24 Summit, The Dedham Group's Jennifer (Goldenberg) Klarer, M.Sc.Eng. will discuss data-driven insights and key takeaways for navigating the ever-evolving pharmaceutical landscape in her presentation, "From Pipeline to Patient: Understanding Barriers to Access in 2024 and Beyond." Don't miss it! https://ow.ly/PawP50R4alQ #Asembia24
To view or add a comment, sign in
-
Tomorrow is the #modularcontent webinar. Very recommended for all that focus on #personaization and content automation.
CTO at Viseven, Creator of eWizard - Revolutionizing Digital Marketing in Healthcare | I provide digital and automation solutions for pharma
Last call to join us for a webinar on modular content! Hosted by Anna Malivska, Product Manager at eWizard, this event promises to deliver valuable insights from years of working with modular content in the pharmaceutical industry. Register here: https://lnkd.in/euSJV8P8 #modularcontent
To view or add a comment, sign in
-
-
Beyond the Hype: Is There Value in Questioning the Popular Narrative? "Don't be afraid to be a contrarian" was advice I was given from one of my early mentors, Peter Kiener, that to this day I try to follow. It isn't always easy to do as narratives have a way of gaining momentum and traction. Take for example the "Global to Local" phenomenon that swept through the #pharma industry starting in mid 2010's impacting #contentcreation and #mlr. Global-to-Local is so hard to execute given how unique and complex each individual market is - not to mention how different labeling is from one region to another. After years of pursuit and massive infrastructure investment (teams, process, and systems), I've yet to see reliable data that suggests that a Global to Local content supply chain results in cost savings, increased content re-use, and decreased time to market. I've been a contrarian on global-to-local for years even while helping teams work through strategy and execution and set reasonable objectives, so it was incredibly refreshing yesterday to hear Anna Malivska talk about the importance of localization of content and that the 'majority of content is created at the local level'. I'd love to see more teams embrace this mindset as doing so may unlock the ability to realize benefits such as: increased content replication at local level and decreased time to market. It was a great presentation with some key insights on lessons learned by the Viseven team. Thank you to Oksana Matviienko for the suggestion to join the webinar. ------------------- Hi, I’m Rebecca (Burnett) Zobbe and I love sharing stories and connecting teams to solutions that drive #awareness, #health, #wellness, and #growth. If you enjoy my content, follow me for more in the #future. https://lnkd.in/gUtvVdJn
CTO at Viseven, Creator of eWizard - Revolutionizing Digital Marketing in Healthcare | I provide digital and automation solutions for pharma
Last call to join us for a webinar on modular content! Hosted by Anna Malivska, Product Manager at eWizard, this event promises to deliver valuable insights from years of working with modular content in the pharmaceutical industry. Register here: https://lnkd.in/euSJV8P8 #modularcontent
To view or add a comment, sign in
-
-
Navigate the complex process of prioritising multi-indication assets Discover key questions and insights to make informed decisions in our latest article on the pharmaceutical industry here: https://lnkd.in/gBW-4XBj
To view or add a comment, sign in
-
-
In part two of my recent interview series with Rose McNulty of AJMC - The American Journal of Managed Care, I'm discussing how unintended consequences of the Inflation Reduction Act could impact patients. The study I authored with Drs. James Motyka and John O'Brien found that increased utilization management requirements, which are likely in response to the #IRA, could reduce patient access — exactly the opposite of what the program intends to do. This is why ensuring that the patient perspective is incorporated into both the implementation process and the ongoing evaluation of the law's unintended consequences is critical! Check out the video here: https://lnkd.in/ewsAR_MK
In an interview with AJMC - The American Journal of Managed Care, NPC's Senior Director of Research Dr. Julie Patterson discusses the findings of a recent NPC study (https://lnkd.in/e6XY2F4y) — specifically the ways in which possible unintended effects of the #IRA could impact patients and the pharmaceutical industry at large. Watch here: https://lnkd.in/eUkjzvdS
To view or add a comment, sign in
-
-
🤔 How do leading life science companies build a cost-effective automated data processing pipeline? 📖 Read about our partnership with Avadel Pharmaceuticals, a leading specialty pharmaceutical company, to learn how we helped: ✅ Reduce Avadel’s data processing time by 95% ✅ Free up Avadel’s employees to focus on other priorities ✅ Develop a product that was cost-effective compared to a large data warehouse, saving Avadel money and time 👇 Full case study: https://bit.ly/3Ir9i3W
To view or add a comment, sign in
-
Consumer and community engagement Manager, Motivational Speaker, Co-Principal Investigator, Patient engagement of Parkinson's Dieasese , WPC Ambassador 2023,
If you missed the WPC here’s your chance to see s bit of what went on and the latest science
Videotaped during the WPC, you can now watch all of the #WPC2023 Master Class videos here: https://lnkd.in/dHTd4RVu These are short talks given by experts on the topics they presented on at WPC 2023. We want to thank the experts who took time out of their days while at the Congress to record these short talks. We also want to thank the sponsors who made this possible: Supernus Pharmaceuticals, Inc., Amneal Pharmaceuticals ESTEVE
To view or add a comment, sign in
-